Novel genetic mechanisms may serve as therapeutic target against glioma

Graphical abstract. Journal of Clinical Investigation (2024) https://doi.org/10.1172/JCI173789 A study from the laboratory of Shi-Yuan Cheng, Ph.D., professor in the Ken and Ruth Davee Department of Neurology’s Division of Neuro-oncology, has identified novel mechanisms underlying RNA splicing events within glioma tumor cells, mechanisms which may serve as novel therapeutic targets, according to findings published in the Journal of Clinical Investigation. “We found another way to treat glioma through the alternative splicing perspective, and we found some novel targets which have not been identified before but are important for glioma malignancy,” Read More